| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/13/2011 | EP2308847A1 Substituted pyridines as inhibitors of dipeptidyl peptidase IV and their application for the treatment of diabetes and related diseases |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308843A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308828A2 CaSR antagonist |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2307401A2 Antineoplastic derivatives of 4-oxo-1,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 04/13/2011 | EP2307380A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/13/2011 | EP2307379A2 Organic compounds |
| 04/13/2011 | EP2307378A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307377A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307376A1 Novel phenylamino isonicotinamide compounds |
| 04/13/2011 | EP2307375A1 Phenanthrenone compounds, compositions and methods |
| 04/13/2011 | EP2307374A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 04/13/2011 | EP2307373A1 A process for preparing atovaquone and associate intermediates |
| 04/13/2011 | EP2307372A1 Heterocyclic antiviral compounds |
| 04/13/2011 | EP2307371A2 Organic compounds |
| 04/13/2011 | EP2307370A1 Sulfoximinamide compounds for combating animal pests |
| 04/13/2011 | EP2307369A1 Marker reagents with a pyridine ring with a diazomethyl function substituent methods for synthesis of said reagents and methods for detecting biological molecules |
| 04/13/2011 | EP2307368A1 Compound comprising phenyl pyridine units |
| 04/13/2011 | EP2307367A2 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 04/13/2011 | EP2307343A1 Process for the epimerization of atovaquone isomer, atovaquone intermediates and mixture thereof |
| 04/13/2011 | EP2307023A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| 04/13/2011 | EP2306828A1 Prolyl hydroxylase inhibitors |
| 04/13/2011 | EP1548005B1 Process for producing 2-substituted pyridine derivative |
| 04/13/2011 | CN1958568B A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
| 04/13/2011 | CN1889920B Microcapsules with uv filter activity and process for producing them |
| 04/13/2011 | CN1826320B N- not 2-(2-pyridinyl)ethyl|benzamide compounds and their use as fungicides |
| 04/13/2011 | CN102017215A Composition containing nitrogenous heterocyclic compounds |
| 04/13/2011 | CN102015820A Polymeric compound having residue of nitrogenated heterocyclic compound |
| 04/13/2011 | CN102015649A Method for manufacturing aryl carboxamides |
| 04/13/2011 | CN102015648A Perpropionic acid composition that is stable in a basic medium |
| 04/13/2011 | CN102015647A Process for production of compound having antagonistic activity on NPYY5 receptor, and useful crystal |
| 04/13/2011 | CN102015646A Azomethine direct dyes or reduced precursors of these dyes obtained from 2-amino-3-hydroxypyridine, and hair dyeing process using these dyes and precursors |
| 04/13/2011 | CN102015634A Pesticides |
| 04/13/2011 | CN102015626A 4-trimethylammonio-butyrates as CPT2 inhibitors |
| 04/13/2011 | CN102015606A IRE-1a inhibitors |
| 04/13/2011 | CN102010371A Proline ionic liquid and preparation method and application thereof |
| 04/13/2011 | CN102010367A Preparation process of high-purity 4-chloro-2-pyridinecarboxylate hydrochloride |
| 04/13/2011 | CN102010366A 2,6-dichloro-5-fluoronicotinoyl fluorobenzene salicylamide compound as well as preparation and application thereof |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102010283A Method for preparing anion chiral ionic liquid |
| 04/13/2011 | CN101671300B Method for preparing 2-cyano-3, 6-dichloropyridine |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101421230B Novel phenyl-propargylether derivatives |
| 04/12/2011 | US7923565 for respiratory tract diseases characterized by airway obstruction such as asthma and COPD; 3-cyclopropylmethoxy-4-difluoromethoxy-benzoic acid 1-(3-cyclopropylmethoxy-4-difluoromethoxy-phenyl)-2-(3,5-dichloro-1-oxy-pyridin-4-yl)-ethyl ester |
| 04/12/2011 | US7923558 Method for obtaining pure tetrahydrocannabinol |
| 04/12/2011 | US7923461 TNF-α production inhibitors |
| 04/12/2011 | US7923446 Biaryl sulfonamides and methods for using same |
| 04/12/2011 | CA2522435C Inhibitors of akt activity |
| 04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/12/2011 | CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties |
| 04/07/2011 | WO2011041737A2 Gain-of-function bcl-2 inhibitors |
| 04/07/2011 | WO2011039670A1 Novel forms of (2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1h-pyrido[4,3-b] indole) |
| 04/07/2011 | WO2011039528A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
| 04/07/2011 | WO2011015522A3 Process for the manufacture of pharmaceutically active compounds |
| 04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | WO2010051926A8 Novel halogen-substituted compounds |
| 04/07/2011 | WO2009146910A8 4, 6-diphenylpyrid-2-0nes against cancer |
| 04/07/2011 | US20110082299 Method for the preparation of dabigatran |
| 04/07/2011 | US20110082295 Novel curcumin derivative |
| 04/07/2011 | US20110082177 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/07/2011 | US20110082176 Stilbenes and Chalcones for the Prevention and Treatment of Cardiovascular Diseases |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | CA2773618A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
| 04/06/2011 | EP2306789A1 Phenyl-pyridine compounds |
| 04/06/2011 | EP2306788A1 Iridium compounds and devices made therewith |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305647A1 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 04/06/2011 | EP2305641A1 Sulfonamide compound or salt thereof |
| 04/06/2011 | EP2305627A1 Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 04/06/2011 | EP2305256A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/06/2011 | EP2305255A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/06/2011 | EP2303882A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 04/06/2011 | EP2303880A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/06/2011 | EP2303843A2 Fungicidal pyridines |
| 04/06/2011 | EP2303823A1 Novel cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same, a pharmaceutical composition comprising the same and a treatment method of cancer using the same |
| 04/06/2011 | EP2303270A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 04/06/2011 | EP2066631B1 Pyridine borane complexes |
| 04/06/2011 | EP1836149B1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/06/2011 | EP1303479B1 7-, 8- and 9-substituted tetracycline compounds |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN1946680B 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007637A Novel photosensitizer and photovoltaic element |
| 04/06/2011 | CN102001995A Preparation method of 2-hydroxypyridine-N-oxide |
| 04/06/2011 | CN102001994A Preparation and application of novel pyridone human immunodeficiency virus-1 (HIV-1) reverse transcriptase inhibitor |
| 04/06/2011 | CN102001971A N-(4-guanidyl butyl) syringoylagmatine derivatives and pharmaceutical applications thereof |
| 04/06/2011 | CN102001916A 作为药物活性剂的茚衍生物 Indene derivatives as pharmaceutically active agent |
| 04/06/2011 | CN101648911B Purifying method of 4-nitro-3,5-dimethylpyridine-N-oxide |
| 04/06/2011 | CN101607935B Method for synthesizing Gallant-Super by adopting pre-etherification method and taking N, N-dimethyl acetamide as solvent |
| 04/06/2011 | CN101602713B Novel method for synthesizing 2-chloronicotinic acid |
| 04/06/2011 | CN101602712B Novel method for synthesizing 2-fluoro-3-chloro-5-trifluoromethylpyridine |